Abivax S.A. (ABVX)

R&D Expense Growth

21.31%

Fiscal year · Period ending:

ABVX logo

ABVX R&D Expense Growth

Latest reported21.31%
ABVX FY R&D Growth (YoY) (0.00% → 21.31%)
High-resolution chart · PNG

ABVX r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Abivax S.A. R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
21.3121%
42.0214%
113.637%
1.0757%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.